Europe Biodefense Market Size & Outlook, 2021-2030

The biodefense market in Europe is expected to reach a projected revenue of US$ 2,317.7 million by 2030. A compound annual growth rate of 9.4% is expected of Europe biodefense market from 2022 to 2030.
Revenue, 2021 (US$M)
$1,032.2
Forecast, 2030 (US$M)
$2,317.7
CAGR, 2022 - 2030
9.4%
Report Coverage
Europe

Europe biodefense market highlights

  • The Europe biodefense market generated a revenue of USD 1,032.2 million in 2021.
  • The market is expected to grow at a CAGR of 9.4% from 2022 to 2030.
  • In terms of segment, anthrax was the largest revenue generating product in 2021.
  • Radiation/nuclear is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Italy is expected to register the highest CAGR from 2022 to 2030.


Europe data book summary

Market revenue in 2021USD 1,032.2 million
Market revenue in 2030USD 2,317.7 million
Growth rate9.4% (CAGR from 2021 to 2030)
Largest segmentAnthrax
Fastest growing segmentRadiation/nuclear
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnthrax, Small Pox, Botulism, Radiation/nuclear
Key market players worldwideAltimmune Inc, Emergent BioSolutions Inc, Dynavax Technologies, SIGA Technologies Inc, Elusys Therapeutics, Ichor Medical Systems, Cleveland-Cliffs Inc, Bavarian Nordic A/S, Ology Bioservices, Alnylam Pharmaceuticals Inc, XOMA


Other key industry trends

  • In terms of revenue, Europe region accounted for 7.3% of the global biodefense market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,455.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biodefense Market Companies

Name Profile # Employees HQ Website

Europe biodefense market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biodefense market will help companies and investors design strategic landscapes.


Anthrax was the largest segment with a revenue share of 29.04% in 2021. Horizon Databook has segmented the Europe biodefense market based on anthrax, small pox, botulism, radiation/nuclear covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe biodefense market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe biodefense market databook

  • Our clientele includes a mix of biodefense market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biodefense market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biodefense market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe biodefense market size, by country, 2018-2030 (US$M)

Europe Biodefense Market Outlook Share, 2021 & 2030 (US$M)

Europe biodefense market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more